Cargando…

Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006

Antimicrobial drug resistance can hinder gonorrhea prevention and control efforts. In this study, we analyzed historical ciprofloxacin resistance data and gonorrhea incidence data to examine the possible effect of antimicrobial drug resistance on gonorrhea incidence at the population level. We analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chesson, Harrell W., Kirkcaldy, Robert D., Gift, Thomas L., Owusu-Edusei, Kwame, Weinstock, Hillard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966369/
https://www.ncbi.nlm.nih.gov/pubmed/24655615
http://dx.doi.org/10.3201/eid2004.131288
_version_ 1782308900476813312
author Chesson, Harrell W.
Kirkcaldy, Robert D.
Gift, Thomas L.
Owusu-Edusei, Kwame
Weinstock, Hillard S.
author_facet Chesson, Harrell W.
Kirkcaldy, Robert D.
Gift, Thomas L.
Owusu-Edusei, Kwame
Weinstock, Hillard S.
author_sort Chesson, Harrell W.
collection PubMed
description Antimicrobial drug resistance can hinder gonorrhea prevention and control efforts. In this study, we analyzed historical ciprofloxacin resistance data and gonorrhea incidence data to examine the possible effect of antimicrobial drug resistance on gonorrhea incidence at the population level. We analyzed data from the Gonococcal Isolate Surveillance Project and city-level gonorrhea incidence rates from surveillance data for 17 cities during 1991–2006. We found a strong positive association between ciprofloxacin resistance and gonorrhea incidence rates at the city level during this period. Their association was consistent with predictions of mathematical models in which resistance to treatment can increase gonorrhea incidence rates through factors such as increased duration of infection. These findings highlight the possibility of future increases in gonorrhea incidence caused by emerging cephalosporin resistance.
format Online
Article
Text
id pubmed-3966369
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-39663692014-04-02 Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006 Chesson, Harrell W. Kirkcaldy, Robert D. Gift, Thomas L. Owusu-Edusei, Kwame Weinstock, Hillard S. Emerg Infect Dis Research Antimicrobial drug resistance can hinder gonorrhea prevention and control efforts. In this study, we analyzed historical ciprofloxacin resistance data and gonorrhea incidence data to examine the possible effect of antimicrobial drug resistance on gonorrhea incidence at the population level. We analyzed data from the Gonococcal Isolate Surveillance Project and city-level gonorrhea incidence rates from surveillance data for 17 cities during 1991–2006. We found a strong positive association between ciprofloxacin resistance and gonorrhea incidence rates at the city level during this period. Their association was consistent with predictions of mathematical models in which resistance to treatment can increase gonorrhea incidence rates through factors such as increased duration of infection. These findings highlight the possibility of future increases in gonorrhea incidence caused by emerging cephalosporin resistance. Centers for Disease Control and Prevention 2014-04 /pmc/articles/PMC3966369/ /pubmed/24655615 http://dx.doi.org/10.3201/eid2004.131288 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Chesson, Harrell W.
Kirkcaldy, Robert D.
Gift, Thomas L.
Owusu-Edusei, Kwame
Weinstock, Hillard S.
Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
title Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
title_full Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
title_fullStr Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
title_full_unstemmed Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
title_short Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006
title_sort ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, united states, 1991–2006
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966369/
https://www.ncbi.nlm.nih.gov/pubmed/24655615
http://dx.doi.org/10.3201/eid2004.131288
work_keys_str_mv AT chessonharrellw ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006
AT kirkcaldyrobertd ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006
AT giftthomasl ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006
AT owusueduseikwame ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006
AT weinstockhillards ciprofloxacinresistanceandgonorrheaincidenceratesin17citiesunitedstates19912006